BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20445285)

  • 1. [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
    Tanaka Y
    Clin Calcium; 2010 May; 20(5):735-42. PubMed ID: 20445285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y
    Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-RANKL antibody for the treatment of rheumatoid arthritis].
    Tanaka Y
    Clin Calcium; 2011 Aug; 21(8):1223-9. PubMed ID: 21814029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A; Saito E; Wakabayashi T; Suzuki Y
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].
    Tanaka Y
    Clin Calcium; 2010 Oct; 20(10):1545-52. PubMed ID: 20890038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expectation for alleviation of joint destruction in rheumatoid arthritis by new molecular targeting pharmaceutics including anti-rankle antibody].
    Nakamura T
    Clin Calcium; 2009 Mar; 19(3):381-6. PubMed ID: 19252248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].
    Okada Y; Nawata M; Tanaka Y
    Clin Calcium; 2007 Nov; 17(11):1762-8. PubMed ID: 17982198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
    Tanaka Y
    Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of biologic therapies on systemic osteoporosis in patients with rheumatoid arthritis].
    Kotake S; Yago T; Nanke Y
    Nihon Rinsho; 2009 May; 67(5):996-1002. PubMed ID: 19432123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis].
    Suzuki Y
    Clin Calcium; 2007 Jan; 17(1):104-7. PubMed ID: 17211102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].
    Soen S
    Clin Calcium; 2008 Aug; 18(8):1169-75. PubMed ID: 18677056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation-induced bone loss: can it be prevented?
    Romas E; Gillespie MT
    Rheum Dis Clin North Am; 2006 Nov; 32(4):759-73. PubMed ID: 17288976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y
    Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoporosis associated with rheumatoid arthritis].
    Kameda H; Takeuchi T
    Nihon Rinsho; 2003 Feb; 61(2):292-8. PubMed ID: 12638224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab update.
    Lewiecki EM
    Curr Opin Rheumatol; 2009 Jul; 21(4):369-73. PubMed ID: 19424068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis].
    Suzuki Y
    Clin Calcium; 2007 Dec; 17(12):1909-13. PubMed ID: 18057668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone destruction and bone loss in rheumatoid arthritis--mechanism, prevention and treatment].
    Suzuki Y; Ide M; Uehara R; Itoh G
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():407-17. PubMed ID: 11979937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-induced osteoporosis].
    Tanaka Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():394-8. PubMed ID: 18074570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.